Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 2
2007 4
2008 1
2009 3
2011 2
2012 2
2013 1
2014 3
2016 2
2017 3
2018 5
2019 5
2020 3
2021 2
2022 4
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial.
Nitz U, Gluz O, Graeser M, Christgen M, Kuemmel S, Grischke EM, Braun M, Augustin D, Potenberg J, Krauss K, Schumacher C, Forstbauer H, Reimer T, Stefek A, Fischer HH, Pelz E, Zu Eulenburg C, Kates R, Wuerstlein R, Kreipe HH, Harbeck N; WSG-ADAPT investigators. Nitz U, et al. Lancet Oncol. 2022 May;23(5):625-635. doi: 10.1016/S1470-2045(22)00159-0. Epub 2022 Apr 8. Lancet Oncol. 2022. PMID: 35405088 Clinical Trial.
Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer.
Rhiem K, Auber B, Briest S, Dikow N, Ditsch N, Dragicevic N, Grill S, Hahnen E, Horvath J, Jaeger B, Kast K, Kiechle M, Leinert E, Morlot S, Püsken M, Schäfer D, Schott S, Schroeder C, Siebers-Renelt U, Solbach C, Weber-Lassalle N, Witzel I, Zeder-Göß C, Schmutzler RK. Rhiem K, et al. Among authors: briest s. Breast Care (Basel). 2022 Apr;17(2):199-207. doi: 10.1159/000516376. Epub 2021 Jul 19. Breast Care (Basel). 2022. PMID: 35702495 Free PMC article. Review.
Aromatase inhibitors for breast cancer.
Briest S, Davidson NE. Briest S, et al. Rev Endocr Metab Disord. 2007 Sep;8(3):215-28. doi: 10.1007/s11154-007-9039-z. Rev Endocr Metab Disord. 2007. PMID: 17486453 Review.
Changes in Tissue Fluidity Predict Tumor Aggressiveness In Vivo.
Sauer F, Grosser S, Shahryari M, Hayn A, Guo J, Braun J, Briest S, Wolf B, Aktas B, Horn LC, Sack I, Käs JA. Sauer F, et al. Among authors: briest s. Adv Sci (Weinh). 2023 Sep;10(26):e2303523. doi: 10.1002/advs.202303523. Epub 2023 Aug 8. Adv Sci (Weinh). 2023. PMID: 37553780 Free PMC article.
Resemblance of the Recurrence Patterns in Primary Systemic, Primary Surgery and Secondary Oncoplastic Surgery.
Dayan D, Ernst K, Aktas B, Baierl R, Briest S, Dengler M, Dieterle D, Endres A, Engelken K, Faridi A, Frenz H, Hantschmann P, Janni W, Kaiser C, Kokott T, Laufhütte S, Schober F, Ebner F. Dayan D, et al. Among authors: briest s. Curr Oncol. 2022 Nov 17;29(11):8874-8885. doi: 10.3390/curroncol29110698. Curr Oncol. 2022. PMID: 36421351 Free PMC article.
41 results